Our results diverge slightly from the findings of Du et al., who found 100% (19/19) of GBM samples positive for OCT4.34 However, the primers used by those authors did not present a significant difference between the OCT4 and their pseudogenes (our unpublished data). Here, POU5F1 is linked to glioblastoma.